Clinical spectrum and treatment of thyroid lymphoma: results of a cohort study of 61 patients - Scorecard - MDSpire

Clinical spectrum and treatment of thyroid lymphoma: results of a cohort study of 61 patients

  • By

  • Shuchang Li

  • Wenjie Gu

  • Zhenzhen Yang

  • Honghan Qiao

  • Feiyang Zong

  • Shifeng Hao

  • Yuxiao Chang

  • Wanyue Zhao

  • Xiang Gao

  • Xudong Zhang

  • Qingjiang Chen

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Clinical Features and Treatment Approaches for Thyroid Lymphoma: Findings from a Study of 61 Patients

At a Glance

CategoryDetail
Condition
Key MechanismsDiagnosis is challenging due to non-specific clinical features; management controversies exist, particularly regarding treatment approaches in patients with concurrent Hashimoto’s thyroiditis.
Target Population
Care Setting

Key Highlights

  • Chemotherapy was associated with improved progression-free survival (PFS) and overall survival (OS), highlighting its importance in treatment.

Guideline-Based Recommendations

Diagnosis

  • Thyroid lymphoma diagnosed based on histopathology and immunohistochemistry, following the 2022 WHO classification.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with pathologically confirmed thyroid lymphoma.

        Chemotherapy exposure defined as receipt of at least one cycle of systemic chemotherapy or immunochemotherapy.

        Clinical Best Practices

        • Utilize Ann Arbor staging for management of thyroid lymphoma, incorporating modern imaging techniques for accurate assessment.

        Related Resources & Content

        Original Source(s)

        Related Content